Preclinical evaluation of topically-administered PEGylated Fab' lung toxicity
PEGylation is a promising approach to increase the residence time of antibody fragments in the lungs and sustain their therapeutic effects. However, concerns arise as to the potential pulmonary toxicity of antibody fragments conjugated to high molecular weight (HMW) polyethylene glycol (PEG), notabl...
Saved in:
Main Authors: | Danielle Freches (Author), Natacha Rocks (Author), Harshad P. Patil (Author), Fabienne Perin (Author), Jacques Van Snick (Author), Rita Vanbever (Author), Didier Cataldo (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel anti-NGF PEGylated Fab' provides analgesia with lower risk of adverse effects
by: Yukari Koya, et al.
Published: (2023) -
Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity
by: Sophia Sheikh, et al.
Published: (2024) -
Interpretation of Metal Fab Drawings
by: Moran, Cameren
Published: (2021) -
Extending the in vivo Half-Life of Adalimumab Fab via Sortase A-Mediated Conjugation of Adalimumab Fab with Modified Fatty Acids
by: Qing-Bin Zhang, et al.
Published: (2020) -
Information System For Administering Preclinical Clerkship In The Faculty Of Dentistry UMS
by: Dawud, Muhammad, et al.
Published: (2015)